PARP1 and brain disorder: Overall, the overexpression of PARP-1 in a multitude of brain diseases and the capacity of PARP-1 inhibitors to penetrate the BBB, places this enzyme as a desirable therapeutic target for brain disorders that share chronic inflammation and/or oxidative stress and a high rate of DNA damage.